abstract |
The present invention provides antibodies that bind to CXC chemokine receptor (4) (CXCR4) and do not induce significant apoptosis of cells expressing CXCR4. The present invention also provides inter alia immunoconjugates and compositions comprising such antibodies, particularly methods and uses associated with such antibodies in the medical and diagnostic arts. |